Bioceltix S.A. announced a private placement of 140,536 common shares at the price of PLN 30 per share for gross proceeds of PLN 4.21608 million on July 18, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.5 PLN | -2.04% |
|
-3.70% | -30.56% |
29/05 | Bioceltix S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
26/04 | Bioceltix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-30.56% | 6.42Cr | |
-12.56% | 7.87TCr | |
-5.37% | 696.8Cr | |
+25.38% | 370.09Cr | |
-6.12% | 302.89Cr | |
+14.19% | 165.99Cr | |
-7.71% | 119.9Cr | |
-32.50% | 111.73Cr | |
-35.50% | 107.48Cr | |
-28.56% | 93Cr |
- Stock Market
- Equities
- BCX Stock
- News Bioceltix S.A.
- Bioceltix S.A. announced that it expects to receive PLN 4.21608 million in funding